Barclays Plc - Apr 26, 2022 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
10%+ Owner
Signature
Suejean Mott
Stock symbol
PYXS
Transactions as of
Apr 26, 2022
Transactions value $
$0
Form type
4
Date filed
4/27/2022, 03:33 PM
Previous filing
Apr 26, 2022
Next filing
Jul 19, 2022

Barclays Plc is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

a) The reporting persons did not engage in any reportable transactions during the relevant period. The reporting persons are no longer subject to Section 16 as a result of the unwind of certain stock borrow and repurchase transaction activity that did not create, in the reporting persons, a pecuniary interest in the securities. b) Name of Person Filing: (1) Barclays PLC (2) Barclays Bank PLC (controlled by Barclays PLC) c) Address of Principal Business Office or, if none, Residence: (1) Barclays PLC 1 Churchill Place, London, E14 5HP, England (2) Barclays Bank PLC 1 Churchill Place, London, E14 5HP, England (3) Barclays Capital Inc. 745 Seventh Avenue New York, New York 10019 United States